Home > Journals > Minerva Cardioangiologica > Past Issues > Articles online first > Minerva Cardioangiologica 2016 Sep 07





A Journal on Heart and Vascular Diseases

Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752



Minerva Cardioangiologica 2016 Sep 07

language: English

Helicobacter pylori infection and ischemic heart disease: could experimental data lead clinical studies?

Davide G. RIBALDONE 1, Sharmila FAGOONEE 2, Ingrid HICKMAN 3, Fiorella ALTRUDA 4, Giorgio M. SARACCO 1, 3, Rinaldo PELLICANO 1

1 Unit of Gastroenterology, Molinette Hospital, Turin, Italy; 2 Institute for Biostructures and Bioimages (CNR) c/o Molecular Biotechnology Center, University of Turin, Turin, Italy; 3 Department of Nutrition and Dietetics, Princess Alexandra Hospital, Woolloongabba, Australia; 4 Molecular Biotechnology Center, University of Turin, Turin, Italy


Despite the remarkable advances made in primary prevention and treatment, ischemic heart disease (IHD) remains the leading cause of death and a significant cause of disability in developed countries. Since traditional cardiovascular risk factors failed to predict all cases of IHD, there is an intensive research to explore other potential etiologic factors. Among these, numerous studies have considered the theoretical link between IHD and chronic infections, including Helicobacter pylori (H. pylori). Considering that epidemiologic studies have produced conflicting results, due to geographical variations of IHD and H. pylori prevalence as well as heterogeneity of study designs, an alternative way to analyze this topic is to assess if consistency for a biological plausibility exists. In this review we critically analyzed the experimental data on this topic, to assess whether their results could lead future clinical studies.

top of page

Publication History

Cite this article as

Corresponding author e-mail